Costs, Cognitive Abilities and Quality of Life After Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement (CCQ)
Multicenter, prospective, observational study in aortic stenosis (AS) patients undergoing transcatheter aortic valve implantation (TAVI) or high-risk patients undergoing aortic valve replacement (AVR).
The objectives of the study are:
- Description of neurocognitive status before and after transcatheter aortic valve implantation and aortic valve replacement procedures
- Description of Quality of Life (QoL) after these procedures
- Defining the relevance of baseline psychological, emotional and cognitive factors on the outcomes associated to the different treatment modalities
- Assessment of costs associated to each of the above mentioned strategies of treatment, including costs of the index hospitalization and costs of follow-up.
調査の概要
詳細な説明
In Italy, a nation-wide observational study endorsed by the Superior Institute of Health has been previously launched in order to evaluate appropriateness and effectiveness of aortic valve replacement (AVR) and transcatheter aortic valve implantation (TAVI) procedures: the OBservational Study of Effectiveness of AVR-TAVI procedures for severe Aortic steNosis Treatment (OBSERVANT). The present study was designed to complement the national survey on TAVI and AVR procedures including data about costs, cognitive functions and quality of life after these procedures. This integrated framework may help defining the relevance of baseline psychological, emotional and cognitive factors on the outcomes associated to the different treatment modalities and, on the other hand, should enable accurate evaluation of the impact of each kind of treatment on quality of life and neuropsychological functions. These elements could also represent relevant keys to decision-making to the different therapeutic strategies. In addition, we aim to ascertain costs associated to each of the above mentioned strategies of treatment, including costs of the index hospitalization and follow-up costs. Costs estimate, combined to the integrated physical and mental health status outcome for each treatment modality, may represent the background for subsequent cost-effectiveness analyses.
All consecutive patients undergoing transcatheter aortic valve implantation or aortic valve replacement (if age ≥ 80 years or Logistic Euroscore ≥ 15%) for aortic stenosis at participating centers during the period of enrollment will be included in the registry, after release of written informed consent. Allocation of patients to different treatment groups will be performed jointly by a cardiologist and a cardiac surgeon on the basis of a complete clinical framework, independently from the present study and in accordance with available guidelines. Type of treatment (for example, access site for TAVI, type of prosthesis…) will be decided by the physicians based on local clinical practice and general principles of good clinical practice.
The administration of neurocognitive and quality of life questionnaires will be performed before the procedure and after 3 months and 1 year by trained personnel following standard operation procedures defined by a coordinating unit. A telephone and web-based support for operators will be available throughout the entire duration of the study. A common methodology for data collection and analysis is defined to guarantee data reliability and homogeneity of assessments among the participating units. The cost analysis will be coordinated by the Regional Healthcare and Social Agency of the Emilia Romagna Region.
Data will be collected in a web-based database (OBSERVANT) through dedicated Case Records Forms and a final database will be built by merging this database with a separate database for costs and Hospital Discharge Records and Mortality Registry databases.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
-
Bologna、イタリア、40138
- Institute of Cardiology, Azienda Ospedaliero-Universitaria di Bologna
-
-
参加基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- All consecutive patients undergoing TAVI at participating centers during the period of enrollment
- All consecutive patients aged ≥80 years or with Logistic Euroscore ≥15% undergoing AVR at participating centers during the period of enrollment
Exclusion Criteria:
- Absence of informed consent
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:コホート
- 時間の展望:見込みのある
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Transcatheter aortic valve implantation
All consecutive patients undergoing TAVI at participating centres during study period
|
Patients undergoing TAVI with transfemoral, transapical, or any other vascular access
他の名前:
|
|
Aortic Valve Replacement
All consecutive patients aged ≥ 80 years or with Logistic Euroscore≥ 15% undergoing AVR for AS at participating centers during the period of enrollment
|
Surgical AVR, with all kind of commercially available prosthesis (stented, stentless, mechanical)
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Mini Mental State Examination (MMSE)
時間枠:baseline, 3-month, 12-month
|
Changes in cognitive function after transcatheter aortic valve implantation and surgical aortic valve replacement
|
baseline, 3-month, 12-month
|
|
Hospital Anxiety and Depression Scale (HADS)
時間枠:baseline, 3-month, 12-month
|
Changes of emotional status after transcatheter aortic valve implantation and surgical aortic valve replacement
|
baseline, 3-month, 12-month
|
|
Minnesota Living with Heart Failure Questionnaire (MLHFQ)
時間枠:baseline, 3-month, 12-month
|
Changes in quality of life after transcatheter aortic valve implantation and surgical aortic valve replacement
|
baseline, 3-month, 12-month
|
|
In-hospital costs
時間枠:Participants will be followed for the duration of hospital stay, an expected average of 10 days for transcatheter aortic valve implantation and 2 weeks for surgical Aortic Valve Replacement
|
Calculation of precise hospital costs for transcatheter aortic valve implantation and surgical Aortic Valve Replacement, including costs of hospitalization, drugs and devices.
|
Participants will be followed for the duration of hospital stay, an expected average of 10 days for transcatheter aortic valve implantation and 2 weeks for surgical Aortic Valve Replacement
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Myocardial infarction
時間枠:30-day, 12-month and up to 2-year (longest available follow-up)
|
Incidence of myocardial infarction
|
30-day, 12-month and up to 2-year (longest available follow-up)
|
|
Stroke
時間枠:30-day, 12-month and up to 2-year (longest available follow-up)
|
Incidence of stroke
|
30-day, 12-month and up to 2-year (longest available follow-up)
|
|
Pace-maker implantation
時間枠:30-day, 12-month
|
Need for permanent pacing
|
30-day, 12-month
|
|
Vascular complications
時間枠:30-day
|
Incidence of vascular complications as defined by the VARC
|
30-day
|
|
Bleedings
時間枠:30-day
|
Incidence of bleedings as defined by the VARC
|
30-day
|
|
Acute kidney injury
時間枠:30-day
|
Incidence of AKI as defined by the VARC
|
30-day
|
|
Follow-up costs
時間枠:12-month
|
Evaluation of costs during follow-up, including new hospital admissions, outpatient clinic and drugs
|
12-month
|
協力者と研究者
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。